Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Cancer Metastatic to Brain”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableLooking for participantsNCT06280300
What this trial is testing

Multi-disciplinary Care for Brain Metastases

Who this might be right for
Brain Metastases, Adult
University of Vermont Medical Center 40
Not applicableStudy completedNCT04525053
What this trial is testing

Dosimetric Validation of Scans Generated by GAN From Pre-therapeutic MRI in Stereotactic Cerebral Radiotherapy

Who this might be right for
Brain Metastases
University Hospital, Brest 184
Not applicableEnded earlyNCT04462419
What this trial is testing

18F-fluciclovine PET/MRI Imaging for the Detection of Tumor Recurrence After Radiation Injury to the Brain

Who this might be right for
Metastatic Intracranial Malignant NeoplasmRecurrent Intracranial Neoplasm
Mayo Clinic 19
Testing effectiveness (Phase 2)UnknownNCT02452294
What this trial is testing

Buparlisib in Melanoma Patients Suffering From Brain Metastases (BUMPER)

Who this might be right for
Malignant MelanomaMetastases
University Hospital Tuebingen 22
Testing effectiveness (Phase 2)Study completedNCT03526900
What this trial is testing

Atezolizumab in Combination With Carboplatin Plus Pemetrexed in Chemotherapy-naïve Patients With Asymptomatic Brain Metastasis

Who this might be right for
Non-small Cell Lung Cancer Stage IV
Spanish Lung Cancer Group 40
Not applicableEnrolling By InvitationNCT07373951
What this trial is testing

Retrospective Multicenter Study of Patient-level T1CE/FLAIR MRI Deep Learning to Predict EGFR/ALK Driver Status in NSCLC Brain Metastases With External Validation and Survival Analysis

Who this might be right for
Non-Small Cell Lung CancerBrain Metastases
Ming Yang 380
Large-scale testing (Phase 3)UnknownNCT04535739
What this trial is testing

PCI for Patients With ES-SCLC After RCT:a Prospective Randomized Study

Who this might be right for
Small-cell Lung Cancer
Chinese Academy of Medical Sciences 414
Testing effectiveness (Phase 2)Looking for participantsNCT03270059
What this trial is testing

Gadolinium and Ferumoxytol MRI in Diagnosing Patients With Abnormalities in the Central Nervous System

Who this might be right for
Central Nervous System NeoplasmCranial Nerve DisorderMetastatic Malignant Neoplasm in the Brain
OHSU Knight Cancer Institute 150
Large-scale testing (Phase 3)Study completedNCT00138788
What this trial is testing

Brain Metastases Study: Radiotherapy Fractionation Schemes in the Treatment of Brain Metastases

Who this might be right for
Neoplasm MetastasisBrain Neoplasms
St George Hospital, Australia 112
Early research (Phase 1)Ended earlyNCT00805103
What this trial is testing

Perfexion Brain Metastasis

Who this might be right for
Brain Metastases
University Health Network, Toronto 9
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06797622
What this trial is testing

Heterogeneity of 68Ga-FAPI Uptake As Imaging Biomarker in T-DXd Treatment for Brain Metastasis of HER2 Positive Breast Cancer

Who this might be right for
Breast CancerMetastatic Breast Cancer
Fudan University 50
Testing effectiveness (Phase 2)Study completedNCT02798029
What this trial is testing

Frameless Fractionated Stereotactic Radiation in Treating Patients With Brain Metastases

Who this might be right for
Metastatic Malignant Neoplasm in the Brain
M.D. Anderson Cancer Center 35
Testing effectiveness (Phase 2)Ended earlyNCT00068666
What this trial is testing

Temozolomide and Radiation Therapy in Treating Patients With Stage IV Malignant Melanoma With Measurable and Unresectable Cancer of the Central Nervous System

Who this might be right for
Melanoma (Skin)Metastatic Cancer
Alliance for Clinical Trials in Oncology 41
Testing effectiveness (Phase 2)WithdrawnNCT07011849
What this trial is testing

Study of Lenvatinib Plus Pembrolizumab in IO Refractory mRCC Patients With Brain Metastases

Who this might be right for
Renal Cell CarcinomaBrain Metastasis
M.D. Anderson Cancer Center
Not applicableUnknownNCT03721055
What this trial is testing

Fluoroglutamine PET/CT in Imaging Patients With Malignant Tumor

Who this might be right for
CancerMetastatic CancerMetastatic Brain Cancer
Xinhua Hospital, Shanghai Jiao Tong University School of Medicine 60
Testing effectiveness (Phase 2)Study completedNCT04452084
What this trial is testing

Phase 2 Trial in Multiple Brain Metastases Outcomes With HA-SIB-WBRT

Who this might be right for
Brain Metastases
National Cancer Centre, Singapore 42
Testing effectiveness (Phase 2)UnknownNCT00875355
What this trial is testing

Radiation Therapy With or Without Temozolomide in Treating Women With Brain Metastases and Breast Cancer

Who this might be right for
Breast CancerMetastatic Cancer
Institut Curie 100
Testing effectiveness (Phase 2)Study completedNCT01781026
What this trial is testing

Phase 2 Study of Neoadjuvant Vemurafenib in Melanoma Patients With Untreated Brain Metastases

Who this might be right for
Melanoma
Yale University 2
Testing effectiveness (Phase 2)Looking for participantsNCT06016387
What this trial is testing

Tucatinib, Trastuzumab and Capecitabine With Brain and/or Spinal Radiotherapy (XRT) in Patients With HER2+, HER2 Mutated and/or HER2-amplified Metastatic Breast Cancer and Leptomeningeal Disease: A Multi-centre Phase II, Single Arm Feasibility Study

Who this might be right for
HER2-positive Breast CancerLMD
Sunnybrook Health Sciences Centre 30
Early research (Phase 1)Study completedNCT00614978
What this trial is testing

Lapatinib and Temozolomide for the Treatment of Progressive Brain Disease in HER-2 Positive Breast Cancer

Who this might be right for
Metastatic Breast CancerBrain MetastasesHER2 Positive
Jules Bordet Institute 18
Next Page